Previously Nec-1 has been evaluated as potential treatment for a range of pathologies, including ischemia-reperfusion injury [24,25,26,27,28], neurodegeneration [29,30], inflammatory disease [31,32], hepatitis [33] and lethal irradiation [34]. The gene discussed is PCSK1; the disease is Hepatitis.